Archives of Physical Medicine and Rehabilitation
Volume 91, Issue 1 , Pages 30-34 , January 2010

Effect of Intrathecal Baclofen Bolus Injection on Lower Extremity Joint Range of Motion During Gait in Patients With Acquired Brain Injury

References 

  1. Meythaler JM, Guin-Renfroe S, Grabb P, Hadley MN. Long-term continuously infused intrathecal baclofen for spastic-dystonic hypertonia in traumatic brain injury: 1-year experience. Arch Phys Med Rehabil. 1999;80:13–19
  2. Ivanhoe CB, Francisco GE, McGuire JR, Subramanian T, Grissom SP. Intrathecal baclofen management of poststroke spastic hypertonia: implications for function and quality of life. Arch Phys Med Rehabil. 2006;87:1509–1515
  3. Norton BJ, Bomze HA, Sahrmann SA, Eliasson SG. Correlation between gait speed and spasticity at the knee. Phys Ther. 1975;55:355–359
  4. Bohannon RW, Andrews AW. Correlation of knee extensor muscle torque and spasticity with gait speed in patients with stroke. Arch Phys Med Rehabil. 1990;71:330–333
  5. Ada L, Vattanasilp W, O'Dwyer NJ, Crosbie J. Does spasticity contribute to walking dysfunction after stroke?. J Neurol Neurosurg Psychiatry. 1998;64:628–635
  6. Ross SA, Engsberg JR. Relationships between spasticity, strength, gait, and the GMFM-66 in persons with spastic diplegia cerebral palsy. Arch Phys Med Rehabil. 2007;88:1114–1120
  7. van der Krogt MM, Doorenbosch CA, Becher JG, Harlaar J. Walking speed modifies spasticity effects in gastrocnemius and soleus in cerebral palsy gait. Clin Biomech (Bristol, Avon). 2009;24:422–428
  8. Horn TS, Yablon SA, Stokic DS. Effect of intrathecal baclofen bolus injection on temporospatial gait characteristics in patients with acquired brain injury. Arch Phys Med Rehabil. 2005;86:1127–1133
  9. Remy-Neris O, Tiffreau V, Bouilland S, Bussel B. Intrathecal baclofen in subjects with spastic hemiplegia: assessment of the antispastic effect during gait. Arch Phys Med Rehabil. 2003;84:643–650
  10. Caty GD, Detrembleur C, Bleyenheuft C, Deltombe T, Lejeune TM. Effect of simultaneous botulinum toxin injections into several muscles on impairment, activity, participation, and quality of life among stroke patients presenting with a stiff knee gait. Stroke. 2008;39:2803–2808
  11. Robertson JV, Pradon D, Bensmail D, Fermanian C, Bussel B, Roche N. Relevance of botulinum toxin injection and nerve block of rectus femoris to kinematic and functional parameters of stiff knee gait in hemiplegic adults. Gait Posture. 2009;29:108–112
  12. Abel MF, Damiano DL, Gilgannon M, et al. Biomechanical changes in gait following selective dorsal rhizotomy. J Neurosurg. 2005;102:157–162
  13. Engsberg JR, Ross SA, Collins DR, Park TS. Effect of selective dorsal rhizotomy in the treatment of children with cerebral palsy. J Neurosurg. 2006;105:8–15
  14. Kim CM, Eng JJ. Magnitude and pattern of 3D kinematic and kinetic gait profiles in persons with stroke: relationship to walking speed. Gait Posture. 2004;20:140–146
  15. Ashworth B. Preliminary trial of carisoprodol in multiple sclerosis. Practitioner. 1964;192:540–542
  16. Kadaba MP, Ramakrishnan HK, Wootten ME. Measurement of lower extremity kinematics during level walking. J Orthop Res. 1990;8:383–392
  17. Olney SJ, Griffin MP, McBride ID. Temporal, kinematic, and kinetic variables related to gait speed in subjects with hemiplegia: a regression approach. Phys Ther. 1994;74:872–885
  18. Tuzson AE, Granata KP, Abel MF. Spastic velocity threshold constrains functional performance in cerebral palsy. Arch Phys Med Rehabil. 2003;84:1363–1368
  19. Kofler M, Quirbach E, Schauer R, Singer M, Saltuari L. Limitations of intrathecal baclofen for spastic hemiparesis following stroke. Neurorehabil Neural Repair. 2009;23:26–31
  20. Sinkjaer T, Magnussen I. Passive, intrinsic and reflex-mediated stiffness in the ankle extensors of hemiparetic patients. Brain. 1994;117:355–363

 Supported in part by the National Institute on Disability and Rehabilitation Research (grant nos. H133A020514 and H133A980035), the U.S. Department of Education, Medtronic, Inc, research grants, and the Wilson Research Foundation, Jackson, MS.

 A commercial party having a direct financial interest in the results of the research supporting this article has conferred or will confer a financial benefit on the author or one or more of the authors. Yablon is a consultant for Medtronic Inc, which manufactures intrathecal baclofen pumps.

 Reprints are not available from the author.

 Published online November 13, 2009 at www.archives-pmr.org.

PII: S0003-9993(09)00756-4

doi: 10.1016/j.apmr.2009.08.148

Archives of Physical Medicine and Rehabilitation
Volume 91, Issue 1 , Pages 30-34 , January 2010

Article Tools

* Image Usage & Resolution